🚀 VC round data is live in beta, check it out!
Ryman Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ryman Healthcare and similar public comparables like Ambea, Summerset Group Holdings, InnovAge, Regis Healthcare and more.
Ryman Healthcare Overview
About Ryman Healthcare
Ryman Healthcare Ltd develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.
Founded
1984
HQ
Employees
150
Website
Sectors
Financials (LTM)
EV
$1B
Ryman Healthcare Financials
Ryman Healthcare reported last 12-month revenue of $522M and EBITDA of $36M.
In the same LTM period, Ryman Healthcare generated $36M in EBITDA and $30M in net income.
Revenue (LTM)
Ryman Healthcare P&L
In the most recent fiscal year, Ryman Healthcare reported revenue of $478M and EBITDA of ($16M).
Ryman Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $522M | XXX | $478M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $420M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 88% | XXX | XXX | XXX |
| EBITDA | $36M | XXX | ($16M) | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (3%) | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 26% | XXX | XXX | XXX |
| Net Profit | $30M | XXX | ($257M) | XXX | XXX | XXX |
| Net Margin | 6% | XXX | (54%) | XXX | XXX | XXX |
| Net Debt | — | — | $980M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ryman Healthcare Stock Performance
Ryman Healthcare has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Ryman Healthcare's stock price is $1.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.0% | XXX | XXX | XXX | $-0.25 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRyman Healthcare Valuation Multiples
Ryman Healthcare trades at 2.3x EV/Revenue multiple, and 33.0x EV/EBITDA.
EV / Revenue (LTM)
Ryman Healthcare Financial Valuation Multiples
As of April 19, 2026, Ryman Healthcare has market cap of $1B and EV of $1B.
Equity research analysts estimate Ryman Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ryman Healthcare has a P/E ratio of 40.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 33.0x | XXX | (74.8x) | XXX | XXX | XXX |
| EV/EBIT | 14.0x | XXX | 9.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.8x | XXX | XXX | XXX |
| P/E | 40.3x | XXX | (4.7x) | XXX | XXX | XXX |
| EV/FCF | 20.8x | XXX | 6.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ryman Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ryman Healthcare Margins & Growth Rates
Ryman Healthcare's revenue in the last 12 month grew by 32%.
Ryman Healthcare's revenue per employee in the last FY averaged $3.2M, while opex per employee averaged $3.3M for the same period.
Ryman Healthcare's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ryman Healthcare's rule of X is 86% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ryman Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 32% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Growth | 62% | XXX | (319%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 39% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 86% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $3.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $3.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 63% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ryman Healthcare Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ryman Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Ambea | XXX | XXX | XXX | XXX | XXX | XXX |
| Summerset Group Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| InnovAge | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Healthcare Services Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ryman Healthcare M&A Activity
Ryman Healthcare acquired XXX companies to date.
Last acquisition by Ryman Healthcare was on XXXXXXXX, XXXXX. Ryman Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ryman Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRyman Healthcare Investment Activity
Ryman Healthcare invested in XXX companies to date.
Ryman Healthcare made its latest investment on XXXXXXXX, XXXXX. Ryman Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ryman Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ryman Healthcare
| When was Ryman Healthcare founded? | Ryman Healthcare was founded in 1984. |
| Where is Ryman Healthcare headquartered? | Ryman Healthcare is headquartered in New Zealand. |
| How many employees does Ryman Healthcare have? | As of today, Ryman Healthcare has over 150 employees. |
| Is Ryman Healthcare publicly listed? | Yes, Ryman Healthcare is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Ryman Healthcare? | Ryman Healthcare trades under RYM ticker. |
| When did Ryman Healthcare go public? | Ryman Healthcare went public in 1999. |
| Who are competitors of Ryman Healthcare? | Ryman Healthcare main competitors are Ambea, Summerset Group Holdings, InnovAge, Regis Healthcare. |
| What is the current market cap of Ryman Healthcare? | Ryman Healthcare's current market cap is $1B. |
| What is the current revenue of Ryman Healthcare? | Ryman Healthcare's last 12 months revenue is $522M. |
| What is the current revenue growth of Ryman Healthcare? | Ryman Healthcare revenue growth (NTM/LTM) is 32%. |
| What is the current EV/Revenue multiple of Ryman Healthcare? | Current revenue multiple of Ryman Healthcare is 2.3x. |
| Is Ryman Healthcare profitable? | Yes, Ryman Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ryman Healthcare? | Ryman Healthcare's last 12 months EBITDA is $36M. |
| What is Ryman Healthcare's EBITDA margin? | Ryman Healthcare's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Ryman Healthcare? | Current EBITDA multiple of Ryman Healthcare is 33.0x. |
| What is the current FCF of Ryman Healthcare? | Ryman Healthcare's last 12 months FCF is $58M. |
| What is Ryman Healthcare's FCF margin? | Ryman Healthcare's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Ryman Healthcare? | Current FCF multiple of Ryman Healthcare is 20.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.